Monogram Technologies Inc. Stock

Equities

MGRM

US6097861081

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2024-06-18 EDT 5-day change 1st Jan Change
2.1 USD +6.60% Intraday chart for Monogram Technologies Inc. -0.47% -38.95%
Sales 2024 * - Sales 2025 * 5.66M 7.76M Capitalization 66.51M 91.24M
Net income 2024 * -12M -16.46M Net income 2025 * -14M -19.21M EV / Sales 2024 * -
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 11.8 x
P/E ratio 2024 *
-5.25 x
P/E ratio 2025 *
-4.57 x
Employees 28
Yield 2024 *
-
Yield 2025 *
-
Free-Float 62.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.60%
1 week-0.47%
Current month+5.53%
1 month+1.45%
3 months+10.53%
6 months-40.68%
Current year-38.95%
More quotes
1 week
1.97
Extreme 1.9667
2.19
1 month
1.88
Extreme 1.88
2.49
Current year
1.53
Extreme 1.53
4.90
1 year
1.53
Extreme 1.53
6.55
3 years
1.53
Extreme 1.53
48.99
5 years
1.53
Extreme 1.53
48.99
10 years
1.53
Extreme 1.53
48.99
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 18-03-31
Founder 54 14-12-31
Director of Finance/CFO 55 22-12-31
Members of the board TitleAgeSince
Director/Board Member 68 22-10-31
Director/Board Member 60 16-03-31
Director/Board Member 68 11-29
More insiders
Date Price Change Volume
24-06-18 2.1 +6.60% 49,352
24-06-17 1.97 -4.37% 55,564
24-06-14 2.06 -0.96% 81,755
24-06-13 2.08 -1.42% 37,007
24-06-12 2.11 -2.76% 43,852

Delayed Quote Nasdaq, June 18, 2024 at 04:00 pm

More quotes
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
Calendar
More about the company